Market research
2B4.F Bonesupport Holding AB (publ)
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 1B
- P/E ratio
- 68.1
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.48
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- SE0009858152
- Market cap
- 1B
- P/E ratio
- 68.1
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.48
About
About Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 2B4.F discussion.
5 years, 5 months ago
Bonesupport Holding AB (publ) is currently in a long term uptrend where the price is trading 14.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.1.
Bonesupport Holding AB (publ)'s total revenue rose by 4.1% to $48M since the same quarter in the previous year.
Its net income has increased by 48.0% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 45.5% to $-22M since the same quarter in the previous year.
Based on the above factors, Bonesupport Holding AB (publ) gets an overall score of 5/5.